Form4insider filings, from the source

SEC Form 4 · accession 0001127602-16-044367

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeffrey L Wade
Officer — EVP, Corp Adm Affairs and CFO
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 8:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 29, 2016M2,785—A32,044D
Common StockF1Feb 29, 2016M2,428—A34,472D
Common StockF1Feb 29, 2016M2,929—A37,401D
Common StockF1Feb 29, 2016M5,807—A43,208D
Common StockFeb 29, 2016F3,815$9.07D39,393D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (Phantom Stock)F1,F3—Feb 29, 2016M2,785D——Common Stock2,7850D
Restricted Stock Units (Phantom Stock)F1,F4—Feb 29, 2016M2,428D——Common Stock2,4282,429D
Restricted Stock Units (Phantom Stock)F1,F5—Feb 29, 2016M2,929D——Common Stock2,9295,857D
Restricted Stock Units (Phantom Stock)F1,F6—Feb 29, 2016M5,807D——Common Stock5,80717,421D

Explanation of responses